|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular Nutrition, Institution of Health Biosciences,The University of Tokushima Graduate School, Tokushima, Japan
2 Tokushima, Japan; Molecular Nutrition, Institution of Health Biosciences,The University of Tokushima Graduate School, Tokushima, Japan
3 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan
* To whom correspondence should be addressed. E-mail: miyamoto{at}nutr.med.tokushima-u.ac.jp.
Recent studies have demonstrated that klotho protein plays a role in calcium/phosphate homeostasis. The goal of the present study was to investigate the regulation of Na/Pi cotransporters in klotho mutant (kl/kl) mice. The kl/kl mice displayed hyperphosphatemia, high plasma 1,25(OH)2D3 levels, increased activity of the renal and intestinal sodium-dependent Pi cotransporters, and increased levels of the type IIa, type IIb, and type IIc transporter proteins when compared with wild-type mice. Interestingly, transcript levels of the type IIa/type IIc transporter mRNA abundance, but not transcripts levels of type IIb transporter mRNA, were markedly decreased in kl/kl mice when compared with wild-type mice. Further, plasma fibroblast growth factor 23 (FGF23) levels were 150-fold higher in kl/kl mice than in wild-type mice. Feeding of a low Pi diet induced the expression of klotho protein and decreased plasma FGF23 levels in kl/kl mice, while colchicine treatment experiments revealed evidence of abnormal membrane trafficking of the type IIa transporter in kl/kl mice. Finally, feeding of a low Pi diet resulted in increased type IIa Na/Pi cotransporter protein in the apical membrane in the wild-type mice but not in kl/kl mice. These results indicate that hyperphosphatemia in klotho mice is due to dysregulation of expression and trafficking of the renal type IIa/IIc transporters rather than due to intestinal Pi uptake.
This article has been cited by other articles:
![]() |
T. Nakatani, M. Ohnishi, and M. S. Razzaque Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model FASEB J, November 1, 2009; 23(11): 3702 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Levine, C. R. Kleeman, and A. J. Felsenfeld The Journey From Vitamin D-Resistant Rickets to the Regulation of Renal Phosphate Transport Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1866 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Alexander, T. E. Woudenberg-Vrenken, J. Buurman, H. Dijkman, B. C. J. van der Eerden, J. P.T.M. van Leeuwen, R. J. Bindels, and J. G. Hoenderop Klotho Prevents Renal Calcium Loss J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2371 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Farrow, S. I. Davis, L. J. Summers, and K. E. White Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule J. Am. Soc. Nephrol., May 1, 2009; 20(5): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Segawa, A. Onitsuka, M. Kuwahata, E. Hanabusa, J. Furutani, I. Kaneko, Y. Tomoe, F. Aranami, N. Matsumoto, M. Ito, et al. Type IIc Sodium-Dependent Phosphate Transporter Regulates Calcium Metabolism J. Am. Soc. Nephrol., January 1, 2009; 20(1): 104 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Levi and S. Breusegem Renal Phosphate-Transporter Regulatory Proteins and Nephrolithiasis N. Engl. J. Med., September 11, 2008; 359(11): 1171 - 1173. [Full Text] [PDF] |
||||
![]() |
S. Liu and L. D. Quarles How Fibroblast Growth Factor 23 Works J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1637 - 1647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |